Glooko Inc. www.glooko.com has raised $16.5 million to expand the company’s FDA-cleared, HIPAA-compliant platform to enable patients to better manage their diabetes. Canaan Partners www.canaan.com and Medtronic www.medtronicdiavetes.com joined investors The Social + Capital Partnership http://S23p.com and Samsung www.samsungventuresl.com in the financing.
Not only can patients manage their physical health better but their healthcare providers can proactively engage their diabetes populations via a mobile cloud-based platform. Using Glooko’s Bluetooth-enabled MeterSync device, patients are already able to sync data from more than 30 blood glucose monitors with their Apple or android mobile device.
The data is structured for providers in a simple to interpret risk-stratified view via Glooko’s Population tracker™, a population management tool. The data is able to be integrated in to other platforms such as an EHR.
In addition, Glooko enables healthcare providers and patients to create reminders for improved treatment plan adherence, integrate data from popular fitness trackers and biometric tools, plus patients can record food intake and insulin dosage to provide context around changes in their blood glucose readings.